Divi's Laboratories profit and loss

Latest FY26
Revenue
₹10,560cr+12.8% on FY25
EBITDA
₹3,441cr+15.9% on FY25
Net profit
₹2,568cr+17.2% on FY25
EPS
₹96.75+17.2% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
11,23010,5609,3607,8457,768
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
452507352339345
11,68211,0679,7128,1848,112
Expenses
4,8714,3783,8213,2323,008
0.00.00.06.022.3
−748−285−96.0−10923.0
1,5101,4421,2431,094975
26.023.02.03.00.7
484463402378343
1,6301,5841,4241,4171,371
7,7737,6056,7966,0215,744
3,9673,4412,9682,2052,368
3,4832,9782,5661,8272,025
Profit
3,9093,4622,9162,1632,369
−74.0−74.00.00.00.0
3,8353,3882,9162,1632,369
968868799514439
−58.0−48.0−74.049.0106
910820725563545
2,9252,5682,1911,6001,823
2,9252,5682,1911,6001,823
20.021.03.00.011.9
2,9452,5892,1941,6001,835
2,9252,5682,1911,6001,823
Per share
₹110.21₹96.75₹82.53₹60.27₹68.69
₹110.21₹96.75₹82.53₹60.27₹68.69
Other comprehensive income — detail
20.021.03.0——
11.08.0−3.0−2.03.6
3.02.01.0——
———−1.01.3
17.020.06.02.011.8
5.05.0−1.0——
———1.02.2
2,9452,5892,1941,6001,835
Per share — as-filed variants
₹110.21₹96.75₹82.53₹60.27₹68.69
₹110.21₹96.75₹82.53₹60.27₹68.69
Derived — gross profit (revenue − materials − purchases − Δ inventories)
7,1076,4675,6354,7164,714
63.3%61.2%60.2%60.1%60.7%
Adjusted (ex-exceptional items) — derived
3,9093,4622,9162,1632,369
−74.0−74.00.00.00.0
2,9812,6242,1911,6001,823
₹112.34₹98.86₹82.53₹60.27₹68.69
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

DIVISLAB₹9,558.50

Divi's Laboratories Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersLAURUSLABSCOHANCEGLANDTORNTPHARMZYDUSLIFEMAXHEALTHDRREDDYCIPLAMcap ₹2.53L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations7,767.57,845.09,360.010,560.011,230.0
Other Income344.7339.0352.0507.0452.0
Total Income8,112.28,184.09,712.011,067.011,682.0
Expenses
+ Cost of Materials Consumed3,008.43,232.03,821.04,378.04,871.0
+ Purchases of Stock-in-Trade22.36.00.00.00.0
+ Changes in Inventories23.0-109.0-96.0-285.0-748.0
+ Employee Benefit Expense975.01,094.01,243.01,442.01,510.0
+ Finance Costs0.73.02.023.026.0
+ Depreciation & Amortisation343.2378.0402.0463.0484.0
+ Other Expenses1,371.01,417.01,424.01,584.01,630.0
Total Expenses5,743.56,021.06,796.07,605.07,773.0
EBITDA2,367.82,205.02,968.03,441.03,967.0
EBIT2,024.61,827.02,566.02,978.03,483.0
Profit
PBT before Exceptional Items2,368.62,163.02,916.03,462.03,909.0
+ Exceptional Items0.00.00.0-74.0-74.0
Pretax Income2,368.62,163.02,916.03,388.03,835.0
+ Current Tax439.2514.0799.0868.0968.0
+ Deferred Tax106.149.0-74.0-48.0-58.0
Tax Expense545.3563.0725.0820.0910.0
Net Income1,823.41,600.02,191.02,568.02,925.0
+ Net Income — Continuing Ops1,823.41,600.02,191.02,568.02,925.0
+ Other Comprehensive Income11.90.03.021.020.0
Total Comprehensive Income1,835.31,600.02,194.02,589.02,945.0
Net Income to Common1,823.41,600.02,191.02,568.02,925.0
Per Share
Basic EPS68.6960.2782.5396.75110.21
Diluted EPS68.6960.2782.5396.75110.21
Other Comprehensive Income — detail
+ Other Comprehensive Income——3.021.020.0
+ Items NOT to be Reclassified to P&L3.6-2.0-3.08.011.0
+ Tax on Items NOT to be Reclassified——1.02.03.0
+ Tax on Items NOT to be Reclassified — alt tag1.3-1.0———
+ Items to be Reclassified to P&L11.82.06.020.017.0
+ Tax on Items to be Reclassified——-1.05.05.0
+ Tax on Items to be Reclassified — alt tag2.21.0———
Comprehensive Income — Owners of Parent1,835.31,600.02,194.02,589.02,945.0
Per Share — as-filed variants
Basic EPS — Continuing Operations68.6960.2782.5396.75110.21
Diluted EPS — Continuing Operations68.6960.2782.5396.75110.21
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit4,713.84,716.05,635.06,467.07,107.0
Gross Margin %60.6960.1160.2061.2463.29
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)2,368.62,163.02,916.03,462.03,909.0
− Exceptional Items (reconciliation)0.00.00.0-74.0-74.0
Net Income Adj (tax-effected)1,823.41,600.02,191.02,624.12,981.4
EPS Adj68.6960.2782.5398.86112.34
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.00
Paid Up Equity Capital53.153.053.053.053.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.